Your browser doesn't support javascript.
COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy.
Gill, Jasmeet; Hebert, Christopher Alan; Colbert, Gates Burton.
  • Gill J; Baylor University Medical Center at Dallas, 3500 Gaston Avenue, Barnett Tower, Ste 904, Dallas, TX, 75246, USA. Gilljasmeet30@gmail.com.
  • Hebert CA; Division of Nephrology, Baylor University Medical Center at Dallas, Dallas, USA.
  • Colbert GB; Division of Nephrology, Baylor University Medical Center at Dallas, Dallas, USA.
J Nephrol ; 35(1): 317-321, 2022 Jan.
Article in English | MEDLINE | ID: covidwho-1370413

Full text: Available Collection: International databases Database: MEDLINE Main subject: Atypical Hemolytic Uremic Syndrome / COVID-19 Type of study: Case report / Diagnostic study / Etiology study / Observational study / Prognostic study Limits: Adult / Humans / Male Language: English Journal: J Nephrol Journal subject: Nephrology Year: 2022 Document Type: Article Affiliation country: S40620-021-01125-8

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Atypical Hemolytic Uremic Syndrome / COVID-19 Type of study: Case report / Diagnostic study / Etiology study / Observational study / Prognostic study Limits: Adult / Humans / Male Language: English Journal: J Nephrol Journal subject: Nephrology Year: 2022 Document Type: Article Affiliation country: S40620-021-01125-8